“A federal advisory panel on Friday unanimously voted to recommend the Food and Drug Administration (FDA) authorize a third booster dose of Pfizer and BioNTech’s coronavirus vaccine for people over the age of 65 as well as for other groups of people who are at high risk for COVID-19.
“But that vote only occurred after the panel overwhelmingly voted against recommending the widespread use of boosters for everyone over the age of 16.
“The move represents a rebuke of the Biden administration and deals an unexpected blow to the president’s plan to administer booster doses to all Americans over 16 beginning Sept. 20.
“The targeted recommendation is much narrower than what the companies and top officials in the Biden administration had initially sought.”
Read more at The Hill
